These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 2670465

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections.
    Peacock JE, Pegram PS, Weber SF, Leone PA.
    Am J Med; 1989 Nov 30; 87(5A):185S-190S. PubMed ID: 2686421
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intravenous ciprofloxacin or ceftazidime in selected infections. A prospective, randomized, controlled study.
    Villavicencio J, Asensio de Fernandez ME, Ramirez CA.
    Am J Med; 1989 Nov 30; 87(5A):191S-194S. PubMed ID: 2686422
    [Abstract] [Full Text] [Related]

  • 5. Ciprofloxacin (intravenous/oral) versus ceftazidime in lower respiratory tract infections.
    Haddow A, Greene S, Heinz G, Wantuck D.
    Am J Med; 1989 Nov 30; 87(5A):113S-115S. PubMed ID: 2686410
    [Abstract] [Full Text] [Related]

  • 6. Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections.
    Fass RJ, Plouffe JF, Russell JA.
    Am J Med; 1989 Nov 30; 87(5A):164S-168S. PubMed ID: 2589361
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intravenous/oral ciprofloxacin therapy versus intravenous ceftazidime therapy for selected bacterial infections.
    Gaut PL, Carron WC, Ching WT, Meyer RD.
    Am J Med; 1989 Nov 30; 87(5A):169S-175S. PubMed ID: 2686417
    [Abstract] [Full Text] [Related]

  • 11. Sequential intravenous/oral ciprofloxacin compared with intravenous ceftazidime in the treatment of serious lower respiratory tract infections.
    Menon L, Ernst JA, Sy ER, Flores D, Pacia A, Lorian V.
    Am J Med; 1989 Nov 30; 87(5A):119S-120S. PubMed ID: 2686412
    [No Abstract] [Full Text] [Related]

  • 12. Randomized study of intravenous/oral ciprofloxacin versus ceftazidime in the treatment of hospital and nursing home patients with lower respiratory tract infections.
    Trenholme GM, Schmitt BA, Spear J, Gvazdinskas LC, Levin S.
    Am J Med; 1989 Nov 30; 87(5A):116S-118S. PubMed ID: 2686411
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intravenous and oral ciprofloxacin versus intravenous ceftazidime for the treatment of severe urinary tract infections.
    Childs SJ.
    Diagn Microbiol Infect Dis; 1990 Nov 30; 13(2):161-3. PubMed ID: 2196152
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of intravenous ciprofloxacin with ceftazidime in the treatment of serious soft tissue infections.
    Tice AD, Marsh PK, Craven PC.
    Diagn Microbiol Infect Dis; 1990 Nov 30; 13(2):165-7. PubMed ID: 2196153
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
    Croom KF, Goa KL.
    Drugs; 2003 Nov 30; 63(24):2769-802. PubMed ID: 14664657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.